Leading technology casts core competitiveness
It is understood that Taimei Medical Technology is actively using cutting-edge cloud computing and big data technology to build SaaS services in the cloud, and is also actively developing and applying data security storage technology, medical intelligent image display technology, medical intelligent image analysis technology, Chinese medical information extraction technology and other underlying technologies. At the same time, the intermediate platform technology built by Taimei Medical Technology has precipitated a low-code rapid development platform specifically for the pharmaceutical industry, effectively supporting the rapid attempt and innovation of Taimei Medical Technology in various scenarios. In addition, in order to actively adapt to the IT development status of domestic enterprises and the needs of business going to sea, Taimei Medical Technology is also actively applying cloud deployment, containerization technology and various cloud computing security technologies to adapt to the IT infrastructure of enterprises and the information compliance requirements of various countries in the future.
Since its establishment, Taimei Medical Technology has clearly defined its business orientation, focused on the digital upgrade and transformation of the pharmaceutical industry, and launched TrialOS pharmaceutical R&D collaboration platform to connect different market participants. Self-developed SaaS products cover drug R&D, pharmacovigilance and drug marketing scenarios. Compared with competitors who develop technical solutions for a certain segment in the market, Taimei Medical Technology can meet the diversified needs of customers in one stop. The interconnected TrialOS platform is convenient for customers to use, improves efficiency, and avoids the inconvenience of manual updating caused by the lack of communication between different softwares, so it has strong competitiveness in business. At the same time, different products enjoy customers and infrastructure, which not only reduces sales costs, improves sales coverage and customer payment potential, but also reduces operating costs.
Brand advantage to build a benchmark enterprise
Since its establishment, Taimei Medical Technology has continuously optimized its business and gained high recognition from the market and customers with its professional product line and excellent service. By June 30th, 2002 1 year, Taimei Medical Technology had accumulated business with about11,000 domestic and foreign pharmaceutical enterprises and CRO enterprises; It has provided digital solutions for more than 360 hospitals/clinical research institutions, and established a good brand awareness and reputation.
In addition, Taimei Medical Technology was selected into "202 1 Hurun Global Unicorn List" and "2020 Hurun Global Unicorn List", "202 1 China Top 100 Digital Medical Enterprises-10 Medical Digital Enterprises" and "20021China Medical Industry Unicorn List". China Taimei Medical Technology, the only one selected in "CB Insights Global Top 50 Digital Healthcare 150" and clinical research field, was selected in "Internet Weekly /eNet Research Institute TOP 100 List of SaaS Enterprises in China in 20/9", ranking 13, which established a good image for Taimei Medical Technology in the industry.
Talent advantage empowers industry development
At the same time, Taimei Medical Technology has a cross-border team composed of professionals in the medical field and talents in the Internet field. The main members of the R&D team come from the well-known Thai-American medical technology in the industry, and they have sufficient talent reserves to support their business network and service quality. Taimei Medical Technology has established a perfect talent training, assessment and incentive mechanism to ensure the high quality, high availability, high reliability and high security of digital solutions. Thai-American medical technology's investment in human capital will bring long-term benefits to Thai-American medical technology, drive Thai-American medical technology to constantly change and innovate, and lead the development of medical digital industry.
Digital solutions in the pharmaceutical industry are highly professional, and customers need to pay higher learning costs and transfer costs, and the product substitution is not high. After forming the habit, they tend to use the same product for a long time, and the accumulation of data will further reduce the possibility of competing products being replaced. As a leading provider of digital medical solutions in China, Taimei Medical Technology has formed a good customer base and has a certain first-Mover advantage. Rich practical experience enables the products to be competent for various business scenarios, and makes Taimei Medical Technology occupy more market share, and is expected to maintain its leading position in the industry for a long time.
Taimei Medical Technology said that it will continue to take the mission of "making good drugs at your fingertips", adhere to the principle of self-research of core technologies, accelerate the upgrading of the company's original core products and the research and development of new products, and strive to become a leading enterprise in the domestic pharmaceutical digital industry. Taking collaboration as the core concept, we will create a collaborative digital environment for pharmaceutical enterprises/sponsors, hospitals/clinical research institutions, third-party service providers (CRO, SMO, central laboratories, cold chain logistics enterprises, etc.), doctors/researchers, patients/subjects, and help form a healthy, prosperous and efficient pharmaceutical industry ecology.